ArtNr |
Z00333-10 |
Hersteller |
GenScript
|
Menge |
10 ug |
Kategorie |
|
Typ |
Proteins |
Specific against |
Human |
Purity |
Greater than 95% as determined by, (a) Analysis by SEC-HPLC (b) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel |
Sequence |
NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
Citations |
Katagiri S, Takahashi Y. Potential relationship between normalization of endometrial epidermal growth factor profile and restoration of fertility in repeat breeder cows. Anim. Reprod. Sci. Sep 2006, 95(1-2): 54-66. Endo K, et al . Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy. Oncol. Rep. Sep 2006, 16(3): 533-541. |
ECLASS 10.1 |
32160409 |
ECLASS 11.0 |
32160409 |
UNSPSC |
12352202 |
Alias |
protein/Z00333-Epidermal_Growth_Factor_EGF_human,Epidermal Growth Factor (EGF), is a polypeptide growth factor which stimulates the proliferation of a wide range of epidermal and epithelial cells. Recombinant human Epidermal Growth Factor (EGF), is a 6,200 Da protein containing 53 amino acid residues.</td></tr><tr><th>M.W.</th><td colspan="7"> 6.0 kDa+/-10% determined by reduced SDS-PAGE</td></tr><tr><th>Purity</th><td colspan="7"> Greater than 95% as determined by, (a) Analysis by SEC-HPLC (b) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel</td></tr><tr><th>Endotoxin Level</th><td colspan="7"> Less than 0.1ng/ug (1 EU/ug) of recombinant human Epidermal Growth Factor (EGF) as determined by LAL test.</td></tr><tr><th>Specific Activity</th><td colspan="7"> The ED50, calculated by the dose-dependant proliferation of murine BALB/c 3T3 cells is less then 2 ng/ml, corresponding to a specific activity of 5.0×105 IU/ mg.</td></tr><tr><th>Storage</th><td colspan="7"> Lyophilized recombinant, Human Epidermal Growth Factor (rhEGF), remains stable up to 12 months at -80C from date of receipt. Upon reconstitution, rhEGF should be stable up to 4 weeks at 4C or up to 6 months at -20C.</td></tr><tr><th>Formulation</th><td colspan="7">Recombinant human Epidermal Growth Factor (EGF), was lyophilized after extensive dialysis against 10mM Phosphate buffer, pH7.0, 200mM NaCl buffer.</td></tr><tr><th>Reconstitution</th><td colspan="7"> It is recommended to reconstitute the lyophilized, recombinant human Epidermal Growth Factor (EGF), in sterile 18 M-cm H2O not less than 100 ug/ml, which can then be further diluted to other aqueous solutions.</td></tr><tr><th>Sequence</th><td colspan="7"> NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR</td></tr><tr><th>Reference</th><td colspan="7">Katagiri S, Takahashi Y. Potential relationship between normalization of endometrial epidermal growth factor profile and restoration of fertility in repeat breeder cows. Anim. Reprod. Sci. Sep 2006, 95(1-2): 54-66. Endo K, et al . Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy. Oncol. Rep. Sep 2006, 16(3): 533-541.</td></tr> |
Similar products |
Epidermal |
Lieferbar |
|
Specificity |
The ED50, calculated by the dose-dependant proliferation of murine BALB/c 3T3 cells is less then 2 ng/ml, corresponding to a specific activity of 5.0x105 IU/ mg. |
Specificity |
The ED50, calculated by the dose-dependant proliferation of murine BALB/c 3T3 cells is less then 2 ng/ml, corresponding to a specific activity of 5.0x105 IU/ mg. |
Description |
Epidermal Growth Factor (EGF), is a polypeptide growth factor which stimulates the proliferation of a wide range of epidermal and epithelial cells. Recombinant human Epidermal Growth Factor (EGF), is a 6, 200 Da protein containing 53 amino acid residues. |
Endotoxin Level |
Less than 0.1ng/ug (1 EU/ug) of recombinant human Epidermal Growth Factor (EGF) as determined by LAL test. |
Formulation |
Recombinant human Epidermal Growth Factor (EGF), was lyophilized after extensive dialysis against 10mM Phosphate buffer, pH7.0, 200mM NaCl buffer. |
M.W. |
6.0 kDa+/-10% determined by reduced SDS-PAGE |
Product Line |
Cytokine, Chemokines & Growth Factors |
Reconstitution |
It is recommended to reconstitute the lyophilized, recombinant human Epidermal Growth Factor (EGF), in sterile 18 M-cm H2O not less than 100 ug/ml, which can then be further diluted to other aqueous solutions. |
Storage |
Lyophilized recombinant, Human Epidermal Growth Factor (rhEGF), remains stable up to 12 months at -80C from date of receipt. Upon reconstitution, rhEGF should be stable up to 4 weeks at 4C or up to 6 months at -20C. |
Manufacturers Category |
Proteins |
Manufacturers Product Line |
Growth Factors |
Product Origin |
USA |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.